Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2018Anticancer ResearchOpen Access

Benzoxazole-based Zn(II) and Cu(II) Complexes Overcome Multidrug-resistance in Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

GSGabriella SpenglerUniversity of SzegedAKAnnamária KincsesUniversity of SzegedBRBálint RáczUniversity of Szeged

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Spengler et al. (2018) studied this question.

synapsesocial.com/papers/6a6fab97f44fa9f079dd2318https://doi.org/10.21873/anticanres.12971
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Perspectives of P-Glycoprotein Modulating Agents in Oncology and Neurodegenerative Diseases: Pharmaceutical, Biological, and Diagnostic Potentials2009 · 122 citations
  2. 2Benzoxazole derivatives: design, synthesis and biological evaluation2018 · 108 citations
  3. 3Reversal of ABC Drug Transporter-Mediated Multidrug Resistance in Cancer Cells: Evaluation of Current Strategies2008 · 25 citations
  4. 4Efflux Pump Inhibitors: A Strategy to Combat P‐Glycoprotein and the NorA Multidrug Resistance Pump2010 · 54 citations
  5. 5How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance?2018 · 129 citations